FAQ
CLIP Philosophy & Business Model
1. What is CLIP?
CLIP is an employer-controlled pharmacy governance and modernization platform. We provide the structural infrastructure for PBMs, TPAs, and self-funded health plans to reclaim strategic sovereignty over high-cost pharmacy spend.
We are not a traditional PBM, a replacement, or a workaround. Instead, CLIP functions as a deterministic governance layer—a data-driven bridge that overlays existing PBM ecosystems to optimize procurement economics while preserving adjudication integrity and clinical safety.
By decoupling high-cost drug procurement from legacy "Black Box" economics, CLIP converts probabilistic estimates into real-time, acquisition-based net pricing to fulfill the fiduciary "Duty of Prudence" for modern plan sponsors.
2. How does CLIP eliminate the conflict of interest common in the industry?
CLIP operates on a Transparent Net Pricing model with a 100% pass-through alignment. This means:
- We eliminate hidden PBM margins, spread pricing, and rebate lag.
- Our model ensures Zero Conflict of Interest because our goals are 100% aligned with finding the lowest net cost for your plan.
- We provide Guaranteed Net Pricing at the claim level.
3. Who does CLIP work with?
We work with a wide range of stakeholders in the healthcare ecosystem:
- PBMs (Pharmacy Benefit Managers)
- TPAs (Third-Party Administrators)
- Self-funded employer groups
- Health plans, unions, and government entities
- Alternative funding plans and stop-loss carriers
- Healthcare brokers and consultants
Solutions & Savings Performance
4. How does CLIP achieve an average 65% total reduction in pharmacy spend?
CLIP delivers measurable savings through its Integrated Cost Containment Engine, a layered strategy. We unify five core cost-containment pillars in a single transparent platform:
- Statutory Drug Acquisition Pricing
- International Prescription Sourcing
- Rebate Aggregation
- Copay Optimization Program
- Generic and Brand Drug Discounts which utilize strategies like Group Purchasing Organizations to secure low acquisition costs
Our average total savings across all drug categories is 65%, with up to 70% reduction in overall drug spend.
5. How does CLIP utilize rebates and copay assistance to save my plan money?
We redefine these programs by applying them instantly, rather than months later:
- Rebate Aggregation: We apply the full rebate value instantly at the point of sale (P.O.S.). This transforms delayed payments into immediate savings on the claim line, providing a true Net Cost instantly.
- Copay Optimization: We capture manufacturer copay assistance (coupons) in real time to fund the member's Out-of-Pocket (OOP) liability. This effectively shifts a significant portion of the plan's financial burden to the drug manufacturer, often resulting in Zero-Cost Specialty Claims.
6. Does CLIP offer a HUB service, and what does it include?
The CLIP Operational HUB is a centralized member engagement and clinical coordination engine. While traditional programs often fail due to manual coordination and fragmented vendor responsibilities, CLIP’s HUB provides a single, unified execution layer.
The HUB service includes four primary pillars of operational excellence:
I. Turnkey Member Activation & Advocacy
The HUB takes full responsibility for moving members from identification to participation without increasing the administrative burden on HR.
- Employer-Led Awareness: We deploy branded, multi-channel communication (Mail, SMS, and Email) to establish program legitimacy.
- Concierge Enrollment: Our team provides white-glove assistance to guide members through the digital enrollment package, including HIPAA releases and terms of service.
-
Omnichannel Support: Members have dedicated access to the HUB via secure messenger, Slack (for Plan Sponsors), and a concierge support line.
II. The "Clinical Bridge" & Provider Integration
CLIP prevents therapy disruption by managing the complex coordination between U.S. physicians and optimized fulfillment channels.
- Prescription Retrieval: The HUB manages standardized prescription retrieval via electronic transfers and Surescripts to remove the burden from the member.
- Clinical Integrity Reviews: Every order undergoes a mandatory "Clinical Bridge Review" by a licensed pharmacist to verify therapeutic equivalence and clinical appropriateness.
- Physician Synchronization: Our HUB initiates proactive outreach to U.S.-licensed prescribers to manage refills and therapeutic synchronization.
III. Regulatory & Compliance Shield (IPIA)
The HUB acts as a protective barrier, ensuring all participation aligns with federal personal importation frameworks.
- Mandatory Attestation (IPIA): We systematically collect member-signed Informed Prescription Insurance Attestations (IPIA) to document voluntary participation.
- The 5-Point Safe Harbor: The HUB ensures every member affirms personal use, 90-day supply limitations, and jurisdiction acknowledgments.
-
Audit-Ready Documentation: Members receive digital PDF records of all authorizations for their personal retention, creating a clear audit trail.
IV. Logistics Oversight & Continuous Care
Beyond enrollment, the HUB serves as the active "Safety Net" for therapy continuity.
- Cold Chain Logistics: For biologics, the HUB utilizes ISTA-accredited shippers and high-fidelity data loggers to monitor temperature throughout transit.
- Proactive Refill Management: We identify prescriptions nearing expiration and initiate electronic renewal requests (RRE) to prevent gaps in care.
- PBM Fallback Enforcement: If an optimized path fails clinical validation or a member opts out, the HUB automatically triggers a fallback to the standard PBM network to ensure therapy is never denied.
The CLIP Operational HUB represents a structural shift from the legacy "passive" mail-order models used by traditional industry competitors. By utilizing a hybrid model that fuses automated digital precision with white-glove personalized advocacy, CLIP eliminates the administrative friction that limits participation in traditional programs.
While legacy vendors often see participation rates stall below 30-40% due to member confusion and manual coordination, CLIP's integrated infrastructure consistently achieves participation rates exceeding 80%.
V. High Engagement & Results
- We have a high participation rate of over 80% for all of our programs.
- This high rate is directly attributed to our Hybrid Approach of digital (SMS/Email) interweaved with human-centric member interaction (phone/live agent support). This approach ensures high adherence and satisfaction.
Compliance, Data & Implementation
7. Is CLIP's data and member communication HIPAA compliant?
Yes. CLIP adheres to the highest regulatory standards, including HIPAA and SOC-2 certification. All patient interactions, PHI exchange, and communications (via text, email, and phone) are securely transmitted, logged, and audit-ready.
8. How long does implementation take?
CLIP offers a clear Implementation Roadmap designed to go from initial data analysis to verified savings in approximately 60 days. The process involves four strategic phases:
- Phase 1: Discovery & Claims Analysis: A detailed audit of pharmacy and medical claims to identify specific cost drivers and high-value savings opportunities.
- Phase 2: Channel Alignment & Design: Strategic alignment of all deterministic cost-containment channels - including domestic and international sourcing, pharmacy network optimization, manufacturer copay assistance, and rebate aggregation to the specific plan design.
-
Phase 3: Implementation & Integration: Full launch utilizing Parallel Deployment Architecture for real-time claim-level adjudication, rebate capture, and HUB service activation.
- Phase 4: Optimization & Validation: Continuous auditing, fiduciary oversight, and transparent reporting to maintain and verify sustained, acquisition-based savings.
9. What kind of reporting and auditability does CLIP offer?
CLIP provides a deterministic financial reporting framework that replaces traditional PBM "probabilistic" estimates with an immutable record of every transaction. Our reporting model is engineered to satisfy the rigorous ERISA "Duty of Prudence" and evolving CAA 2026 transparency standards.
Key components of our reporting ecosystem include:
- Verified Actual Funded Cost (AFC) Reporting: We provide 100% transparency by establishing the Actual Funded Cost as the immutable record of truth for every transaction, eliminating hidden spread and retrospective rebate dependency.
- Consolidated Claims File (CCF) Integration: CLIP bridges "Shadow Claim" data with actual plan funding events. This ensures clear audit traceability and allows stop-loss carriers to accurately verify eligible medical expenses for attachment point integrity.
- Claim-Level Financial Forensics: Every optimized claim includes source validation, channel attribution, and objective validation of the net-cost delta. We provide a full "receipt" for every dollar saved rather than relying on projected or aggregate savings.
- Dynamic Fiduciary Oversight: Plan sponsors have visibility into claim-level outcomes and sourcing efficiency. This eliminates the informational "blind spots" inherent in traditional reconciliation cycles.
-
Automated Regulatory Filings: We maintain a persistent reporting cadence for consolidated RxDC and federal transparency files, providing the documented evidence required to support ongoing fiduciary stewardship.